|
LoRusso, P; Wozniak, A J; Polin, L et al. (1990) Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. Cancer Res 50:4900-5
|
|
Chabot, G G; Bissery, M C; Corbett, T H et al. (1989) Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975;NSC-347512) in mice. Cancer Chemother Pharmacol 24:15-22
|
|
Mucci-LoRusso, P; Polin, L; Bissery, M C et al. (1989) Activity of batracylin (NSC-320846) against solid tumors of mice. Invest New Drugs 7:295-306
|
|
Bissery, M C; Valeriote, F A; Chabot, G G et al. (1988) Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. Cancer Res 48:1279-85
|
|
Tapazoglou, E; Polin, L; Corbett, T H et al. (1988) Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations. Invest New Drugs 6:259-64
|
|
Evelhoch, J L; Keller, N A; Corbett, T H (1987) Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Cancer Res 47:3396-401
|
|
Corbett, T H; Valeriote, F A; Baker, L H (1987) Is the P388 murine tumor no longer adequate as a drug discovery model? Invest New Drugs 5:3-20
|
